XOMA Royalty Corporation
Private
SectorHealth Care
CountryUnited States
XOMA Royalty Corporation: A biotechnology royalty company that acquires and manages economic milestone and royalty rights associated with clinical-stage therapeutic pipelines.
You can't buy this directly — but you can invest in the public parent:
Ligand Pharmaceuticals Incorporated
LGND
Publicly traded alternatives in this space:
Array
Generate Biomedicines, Inc. 
Iovance Biotherapeutics, Inc. 
UFP Technologies, Inc. 
MBX Biosciences, Inc. 
AnaptysBio, Inc.